DENVER--(BUSINESS WIRE)--Colorado BioScience Association (CBSA) focuses on Colorado’s fast-changing demographics and how the state’s life science sector is developing breakthrough therapies to support the state’s population evolution in the new issue of the annual Bioscience Colorado Magazine: Elevating the Quality of Life, released at the 2016 BIO International Convention in San Francisco.
Colorado boasts one of the most rapidly expanding aging populations in the U.S., as well as one of the fastest-growing millennial populations in the country, inspiring life science companies and organizations in the state to focus on research and product development to serve patients across the care continuum. Colorado’s changing demographics have allowed Accera, a company researching Alzheimer’s disease, to open two trial sites in the state.
Additionally, 125 companies focused on digital health and the ‘quantified self’—appealing to health and wellness goals for millennials – are exploding. Another Colorado company, SomaLogic, is developing a wellness chip to enable early detection of diseases and health conditions and monitor well-being.
April Giles, President and CEO of CBSA, says:
“Colorado’s life science sector is leading groundbreaking research to help all of us live better lives. The companies and organizations in our state are focused on fighting disease, finding cures and improving all-around quality of life.”
The magazine also highlights the state’s leadership in the prevention of infectious diseases that impact the health of all generations, with a large concentration of companies focused on outbreak prevention, along with universities and federal labs such as Colorado State University, the Rocky Mountain Centers for Disease Control and Prevention (CDC), the United States Department of Agriculture (USDA), the United States Geological Survey (USGS) and the National Wildlife Research Center (NWRC).
According to the magazine, the state is home to approximately 600 life science companies and organizations that contribute more than $10 billion in annual payroll to Colorado’s economy. Each job in the life science field creates an additional 5.3 jobs to support the industry. Overall, the industry accounts for 159,118 direct and indirect jobs in the state.
Leah Lindahl, Vice President of CBSA, says:
“The state of Colorado deserves credit for the continued expansion of our life science industry. Since 2006, Colorado has awarded more than 333 life-science-related grants and provided more than $37 million in matching grant funding to bioscience ventures. That early investment has generated more than $465.4 million in follow-on grants and investments for these companies, allowing them to launch clinical studies, fund the development of medical devices and bring new drugs to market.”
Comprehensive information on the state’s life science industry, including a complete directory of resources in Colorado, is available in Bioscience Colorado 2016-2017: Elevating the Quality of Life. An electronic version of the magazine is available on the CBSA website.
About the Colorado BioScience Association
Colorado BioScience Association champions life science. We serve as the hub of Colorado’s thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. From promising young companies to established corporations and institutions, we provide opportunities for networking, education and professional development. We grow the bioscience workforce and lead business expansion policies to advance the industry in our state. CBSA represents more than 350 member organizations, including biotechnology, pharmaceutical, medical device, diagnostic, ag bio and mobile digital health companies, research and academic institutions and service providers. Learn more about us at: http://www.cobioscience.com.